Influenza A virus H1N1 vaccine - DNARx
Alternative Names: HINI vaccine - DNARxLatest Information Update: 27 Jul 2021
At a glance
- Originator DNARx
- Class DNA vaccines; Influenza A virus H1N1 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Influenza A virus H1N1 subtype
Most Recent Events
- 27 Jul 2021 Preclinical trials in Influenza A virus H1N1 subtype (Prevention) in USA (DNARx pipeline, July 2021)